✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹450 Cr.
P/E
20.29
About
Chandan Healthcare operates advanced laboratories providing a wide range of pathological investigations such as biochemistry, hematology, histopathology, microbiology, and immunology. They also offer … Read more
Chandan Healthcare operates advanced laboratories providing a wide range of pathological inves… Read more
Low
140
52W Range
High
215
  • Chandan Healthcare
  • Oxygenta Pharma
  • Albert David

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

1 Neutral

Neutral for this company

1 No

Negative for this company

6 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
FAQs on Chandan Healthcare Ltd. Business

Chandan Healthcare specializes in operating state-of-the-art laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provides an extensive array of radiology services, including CT scans, X-rays, and MRIs.

Chandan Healthcare major competitors are Oxygenta Pharma, Albert David, Valiant Laboratories.
Market Cap of Chandan Healthcare is ₹450 Crs.
While the median market cap of its peers are ₹460 Crs.

Chandan Healthcare seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material